marker_accession_id,marker_symbol,phenotyping_center,colony_id,sex,zygosity,allele_accession_id,allele_symbol,allele_name,strain_accession_id,strain_name,project_name,project_fullname,pipeline_name,pipeline_stable_id,procedure_stable_id,procedure_name,parameter_stable_id,parameter_name,top_level_mp_term_id,top_level_mp_term_name,mp_term_id,mp_term_name,p_value,percentage_change,effect_size,statistical_method,resource_name
MGI:2147134,Fbxo11,MRC Harwell,C3H.Cg-Fbxo11<Jf>/H,male,heterozygote,MGI:1862017,Fbxo11<Jf>,jeff,MGI:2159743,C3H/HeH,EUMODIC,European Mouse Disease Clinic,EUMODIC Pipeline 1,ESLIM_001,ESLIM_022_001,Body Weight,ESLIM_022_001_708,Heart Weight/Tibia Length Body Weight,MP:0005378,growth/size/body region phenotype,MP:0001262,decreased body weight,1.21417411680369E-8,-18.02%,-5.45546287090715,"Mixed Model framework, linear mixed-effects model, equation withoutWeight",EuroPhenome
MGI:1350929,Asns,MRC Harwell,EPD0525_1_F01,male,homozygote,MGI:4441742,Asns<tm1a(EUCOMM)Wtsi>,"targeted mutation 1a, Wellcome Trust Sanger Institute",MGI:2164831,C57BL/6NTac,EUMODIC,European Mouse Disease Clinic,EUMODIC Pipeline 1,ESLIM_001,ESLIM_022_001,Body Weight,ESLIM_022_001_708,Heart Weight/Tibia Length Body Weight,MP:0005378,growth/size/body region phenotype,MP:0001262,decreased body weight,3.9419573386601E-6,-13.26%,-3.21146637592459,"Mixed Model framework, linear mixed-effects model, equation withoutWeight",EuroPhenome
MGI:96522,Rbpj,JAX,JR25849,female,homozygote,MGI:5614604,Rbpj<tm1b(EUCOMM)Hmgu>,"targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:3056279,C57BL/6NJ,JAX,Jackson Laboratory,JAX Pipeline,JAX_001,IMPC_VIA_001,Viability Primary Screen,IMPC_VIA_001_001,Outcome,MP:0010768,mortality/aging,MP:0011100,"preweaning lethality, complete penetrance",0.0,,1.0,Unknown,IMPC
MGI:96522,Rbpj,JAX,JR25849,male,homozygote,MGI:5614604,Rbpj<tm1b(EUCOMM)Hmgu>,"targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH",MGI:3056279,C57BL/6NJ,JAX,Jackson Laboratory,JAX Pipeline,JAX_001,IMPC_VIA_001,Viability Primary Screen,IMPC_VIA_001_001,Outcome,MP:0010768,mortality/aging,MP:0011100,"preweaning lethality, complete penetrance",0.0,,1.0,Unknown,IMPC
MGI:88302,Ccnb1,MRC Harwell,H-CCNB1-E11-TM1B,female,homozygote,MGI:5637200,Ccnb1<tm1b(KOMP)Wtsi>,"targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:2164831,C57BL/6NTac,MRC,MRC project,Harwell,HRWL_001,IMPC_VIA_001,Viability Primary Screen,IMPC_VIA_001_001,Outcome,MP:0010768,mortality/aging,MP:0011100,"preweaning lethality, complete penetrance",0.0,,1.0,Unknown,IMPC
MGI:88302,Ccnb1,MRC Harwell,H-CCNB1-E11-TM1B,male,homozygote,MGI:5637200,Ccnb1<tm1b(KOMP)Wtsi>,"targeted mutation 1b, Wellcome Trust Sanger Institute",MGI:2164831,C57BL/6NTac,MRC,MRC project,Harwell,HRWL_001,IMPC_VIA_001,Viability Primary Screen,IMPC_VIA_001_001,Outcome,MP:0010768,mortality/aging,MP:0011100,"preweaning lethality, complete penetrance",0.0,,1.0,Unknown,IMPC
